Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa

Includes bibliographical references. === Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There...

Full description

Bibliographic Details
Main Author:	Njuguna, Christine Wanjiku
Other Authors:	Cox, Helen
Format:	Dissertation
Language:	English
Published:	University of Cape Town 2014
Subjects:	Epidemiology
Online Access:	http://hdl.handle.net/11427/10625

id	ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-10625
record_format	oai_dc
spelling	ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-106252020-10-06T05:10:48Z Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa Njuguna, Christine Wanjiku Cox, Helen Boulle, Andrew Epidemiology Includes bibliographical references. Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There is a scarcity of literature regarding the frequency of hearing loss as well as associated risk factors, particularly with long term use. This study aimed to determine the incidence and risk factors for hearing loss among patients receiving second line injectable drugs. 2014-12-30T19:49:26Z 2014-12-30T19:49:26Z 2013 Master Thesis Masters MPH http://hdl.handle.net/11427/10625 eng application/pdf University of Cape Town Faculty of Health Sciences Department of Public Health and Family Medicine
collection	NDLTD
language	English
format	Dissertation
sources	NDLTD
topic	Epidemiology
spellingShingle	Epidemiology Njuguna, Christine Wanjiku Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
description	Includes bibliographical references. === Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There is a scarcity of literature regarding the frequency of hearing loss as well as associated risk factors, particularly with long term use. This study aimed to determine the incidence and risk factors for hearing loss among patients receiving second line injectable drugs.
author2	Cox, Helen
author_facet	Cox, Helen Njuguna, Christine Wanjiku
author	Njuguna, Christine Wanjiku
author_sort	Njuguna, Christine Wanjiku
title	Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_short	Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_full	Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_fullStr	Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_full_unstemmed	Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_sort	baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (dr-tb) treatment in khayelitsha, south africa
publisher	University of Cape Town
publishDate	2014
url	http://hdl.handle.net/11427/10625
work_keys_str_mv	AT njugunachristinewanjiku baselineprevalenceandincidenceandriskfactorsfornewonsetdruginducedhearinglossinadultsreceivingdrugresistanttuberculosisdrtbtreatmentinkhayelitshasouthafrica
_version_	1719347223519559680

Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa

Similar Items